Skip to main content
Top

2024 | OriginalPaper | Chapter

A Web-Based Vaccine Distribution System for Covid-19 Using Vaxallot

Authors : B. Valarmathi, N. Srinivasa Gupta, G. Prakash, A. BarathyKolappan, N. Padmavathy

Published in: Cognitive Computing and Cyber Physical Systems

Publisher: Springer Nature Switzerland

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Vaxallot seeks to implement a system to distribute vaccines across high-risk groups accounting for various parameters and prove to be superior to what conventional systems are capable of today. It is a Python flask-based tool backed by infrastructure and data resources from the Covid India central repository; all it needs is a single channel input and a single parameter of the value produced, and the algorithm will take care of the rest. Since it’s Python-based and has an active integration with google sheets, live value updating could be possible for the real-time output of the distribution. The novelty of the proposed mechanism is the unique priority index, a score that accounts for an array of factors associated with the pandemic and is computed for regions in question here; this makes way for better distribution of vaccines. The application has an exclusive segment centered on handling excess units, if any. Moreover, since the application is developed to suit the needs of dynamic demographics, any region can roll out this application for purposes they desire to serve the masses. Since it isn’t bound by a coronavirus, it can be used by the healthcare industry as they deem fit.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Plotkin, S., Robinson, J.M., Cunningham, G., Iqbal, R., Larsen, S.: The complexity and cost of vaccine manufacturing - an overview. Vaccine 35(33), 4064–4071 (2017) Plotkin, S., Robinson, J.M., Cunningham, G., Iqbal, R., Larsen, S.: The complexity and cost of vaccine manufacturing - an overview. Vaccine 35(33), 4064–4071 (2017)
2.
go back to reference Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., Larson, H.J.: Strategies for addressing vaccine hesitancy – a systematic review. Vaccine 33(34), 4180–4190 (2015) Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., Larson, H.J.: Strategies for addressing vaccine hesitancy – a systematic review. Vaccine 33(34), 4180–4190 (2015)
3.
go back to reference Cunningham, A.L., et al.: Vaccine development from concept to early clinical testing. Vaccine 34(52), 6655–6664 (2016) Cunningham, A.L., et al.: Vaccine development from concept to early clinical testing. Vaccine 34(52), 6655–6664 (2016)
4.
go back to reference Hosangadi, D., et al.: Enabling emergency mass vaccination: innovations in manufacturing and administration during a pandemic. Vaccine 38(26), 4167–4169 (2020) Hosangadi, D., et al.: Enabling emergency mass vaccination: innovations in manufacturing and administration during a pandemic. Vaccine 38(26), 4167–4169 (2020)
5.
go back to reference Lin, Q., Zhao, Q., Lev, B.: Cold chain transportation decision in the vaccine supply chain. Eur. J. Oper. Res. 283(1), 182–195 (2020) Lin, Q., Zhao, Q., Lev, B.: Cold chain transportation decision in the vaccine supply chain. Eur. J. Oper. Res. 283(1), 182–195 (2020)
6.
go back to reference Larson, H.J., et al.: Measuring vaccine hesitancy: the development of a survey tool. Vaccine 33(34), 4165–4175 (2015) Larson, H.J., et al.: Measuring vaccine hesitancy: the development of a survey tool. Vaccine 33(34), 4165–4175 (2015)
7.
go back to reference Schaefer, G.O., Tam, C.C., Savulescu, J., Voo, T.C.: COVID-19 vaccine development time to consider SARS-CoV-2 challenge studies? Vaccine 38(33), 5065–5088 (2020) Schaefer, G.O., Tam, C.C., Savulescu, J., Voo, T.C.: COVID-19 vaccine development time to consider SARS-CoV-2 challenge studies? Vaccine 38(33), 5065–5088 (2020)
8.
go back to reference Mosina, L., et al.: Building immunization decision-making capacity within the world health organization European region. Vaccine 38(33), 5109–5113 (2020) Mosina, L., et al.: Building immunization decision-making capacity within the world health organization European region. Vaccine 38(33), 5109–5113 (2020)
9.
go back to reference Asturias, E.J., Duclos, P., MacDonald, N.E., Nohynek, H., Lambert, P.-H., The Global Vaccinology Training Collaborative: Advanced vaccinology education landscaping its growth and global footprint. Vaccine 38(30), 4664–4670 (2020) Asturias, E.J., Duclos, P., MacDonald, N.E., Nohynek, H., Lambert, P.-H., The Global Vaccinology Training Collaborative: Advanced vaccinology education landscaping its growth and global footprint. Vaccine 38(30), 4664–4670 (2020)
10.
go back to reference Schuster, M., Eskola, J., Duclos, P.: Review of vaccine hesitancy: rationale, remit and methods. Vaccine 33(34), 4157–4160 (2015) Schuster, M., Eskola, J., Duclos, P.: Review of vaccine hesitancy: rationale, remit and methods. Vaccine 33(34), 4157–4160 (2015)
11.
go back to reference Westrick, S.C., Watcharadamrongkun, S., Mount, J.K., Breland, M.L.: Community pharmacy involvement in vaccine distribution and administration. Vaccine 27(21), 2858–2863 (2009) Westrick, S.C., Watcharadamrongkun, S., Mount, J.K., Breland, M.L.: Community pharmacy involvement in vaccine distribution and administration. Vaccine 27(21), 2858–2863 (2009)
12.
go back to reference Käser, T.: Challenges and efforts in vaccine development and distribution. Vaccine 35(40), 5396 (2017) Käser, T.: Challenges and efforts in vaccine development and distribution. Vaccine 35(40), 5396 (2017)
13.
go back to reference De Boeck, K.., Decouttere, C., Vandaele, N.: Vaccine distribution chains in low- and middle-income countries: a literature review. Omega 97, 102097 (2020) De Boeck, K.., Decouttere, C., Vandaele, N.: Vaccine distribution chains in low- and middle-income countries: a literature review. Omega 97, 102097 (2020)
14.
go back to reference Palache, A., et al.: Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004–2015): the 2003 world health assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. Vaccine 35(36), 4681–4686 (2017) Palache, A., et al.: Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004–2015): the 2003 world health assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. Vaccine 35(36), 4681–4686 (2017)
15.
go back to reference Smith, J., Lipsitch, M., Almond, J.W.: Vaccine production, distribution, access, and uptake. Lancet 378(9789), 428–438 (2011) Smith, J., Lipsitch, M., Almond, J.W.: Vaccine production, distribution, access, and uptake. Lancet 378(9789), 428–438 (2011)
16.
go back to reference Bertsimas, D., et al.: Optimizing vaccine allocation to combat the covid-19 pandemic. Healthc. Manag. Sci., 1–27 (2020) Bertsimas, D., et al.: Optimizing vaccine allocation to combat the covid-19 pandemic. Healthc. Manag. Sci., 1–27 (2020)
17.
go back to reference Chen, S.-I., Norman, B.A., Rajgopal, J., Assi, T.M., Lee, B.Y., Brown, S.T.: A planning model for the WHO-EPI vaccine distribution network in developing countries. IIE Trans. 46(8), 853–865 (2014) Chen, S.-I., Norman, B.A., Rajgopal, J., Assi, T.M., Lee, B.Y., Brown, S.T.: A planning model for the WHO-EPI vaccine distribution network in developing countries. IIE Trans. 46(8), 853–865 (2014)
18.
go back to reference Hu, X., Zhang, J., Chen, H.: Optimal vaccine distribution strategy for different age groups of population: a differential evolution algorithm approach. Math. Probl. Eng., 1–7 (2014) Hu, X., Zhang, J., Chen, H.: Optimal vaccine distribution strategy for different age groups of population: a differential evolution algorithm approach. Math. Probl. Eng., 1–7 (2014)
19.
go back to reference Yu, Z., Liu, J., Wang, X., Zhu, X., Wang, D., Han, G.: Efficient vaccine distribution based on a hybrid compartmental model. PLoS ONE 11(5) (2016) Yu, Z., Liu, J., Wang, X., Zhu, X., Wang, D., Han, G.: Efficient vaccine distribution based on a hybrid compartmental model. PLoS ONE 11(5) (2016)
20.
go back to reference Foy, B.H., et al.: Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study. Int. J. Infect. Dis. 103, 431–438 (2021) Foy, B.H., et al.: Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study. Int. J. Infect. Dis. 103, 431–438 (2021)
Metadata
Title
A Web-Based Vaccine Distribution System for Covid-19 Using Vaxallot
Authors
B. Valarmathi
N. Srinivasa Gupta
G. Prakash
A. BarathyKolappan
N. Padmavathy
Copyright Year
2024
DOI
https://doi.org/10.1007/978-3-031-48891-7_31

Premium Partner